Retrograde transduction of dopaminergic cells in substantia nigra of rhesus monkey

Read full text
Authors: Anya S. Plotnikova, Walter Lerchner, Alexander C. Cummins, Gang Chen, Leonardo Salhani, Vincent D. Costa, Bruno B. Averbeck, Barry J. Richmond, Zayd M. Khaliq, Mark A. G. Eldridge
Cited by: 0
References: 59

Abstract

Neuromodulatory systems regulate neural circuits across broad regions of the brain, and disruption of the dopaminergic system contributes to psychiatric and neurodegenerative disorders. Engineered viral vectors have been used to target the neuromodulatory systems of the nonhuman primate brain (Y. Chen et al., 2023; El-Shamayleh et al., 2016; Gray et al., 2010; Lerchner et al., 2014; Perez et al., 2022). However, a conspicuous obstacle to the isolation and modulation of specific pathways is the inability of many retrogradely infecting viruses to transduce dopaminergic (DA) cells efficiently (Tervo et al., 2016; Cushnie et al., 2020; Weiss et al., 2020). We compare the DA neuron retrograde transduction efficacy of four viral vectors after injection into the striatum of nonhuman primates (NHP). Selectivity was assessed by comparing the neuronal co-expression of fluorescent reporter protein and tyrosine-hydroxylase (TH) antibody in substantia nigra pars compacta (SNc). The rabies pseudotyped lentiviral vector, FuG-B2, produced superior retrograde transduction of DA cells to FuG-C or FuG-E. AAV2.retro was the least effective.

Fields of Study & Subjects

Virus-based gene therapy research Nerve injury and regeneration Neurogenesis and neuroplasticity mechanisms

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publication date
8 January 2026
Language
EN
Document type
Preprint